Gut Microbiota and its impact on the inflammation-dysplasia-cancer sequence

Ivanna Lazarchuk; Shivika Parmar; Slawomir Wozniak

doi:10.2478/acb-2023-0004

.blurhash-client-img { display: none !important; }

Gut Microbiota and its impact on the inflammation-dysplasia-cancer sequence

Medical Journal of Cell Biology

Volume 11 (2023): Issue 1 (July 2023)

By: Ivanna Lazarchuk, Shivika Parmar and Slawomir Wozniak

Open Access

|Aug 2023

Abstract

The understanding and explanation of inflammation-dysplasia-cancer sequence is challenging. The gut microbiota is an important factor for the intestine wall. The changes in bacteria quality and/or quantity (dysbiosis) may begin the colon inflammation. This paper reviewed the gut microbiome risk factors which may lead to colon cancer.

References

Karpiński TM, Ożarowski M, Stasiewicz M. Carcinogenic microbiota and its role in colorectal cancer development. Semin Cancer Biol. 2022;86(Pt3):420-430; DOI:10.1016/j.semcancer.2022.01.004.
Search in Google Scholar Back to article
Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233-254; DOI:10.3322/caac.21772.
Search in Google Scholar Back to article
Wojciechowska U, Baranska K, Michalek I, Olasek P, Miklewska M, Didkowska JA. Zachorowania i zgony na nowotwory złośliwe w Polsce. [Internet]. Warszawa: Polish National Cancer Registry; 2020 [cited 2023 Feb 08] 100 p. Available from: https://onkologia.org.pl/sites/default/files/publications/2023-01/nowotwory_2020.pdf.
Search in Google Scholar Back to article
Cheng Y, Ling Z, Li L. The intestinal microbiota and colorectal cancer. Front Immunol. 2020;11:615056; DOI:10.3389/fimmu.2020.615056.
Search in Google Scholar Back to article
Quaglio AEV, Grillo TG, De Oliveira ECS, Di Stasi LC, Sassaki LY. Gut microbiota, inflammatory bowel disease and colorectal cancer. World J Gastroenterol. 2022;28(30):4053-4060; DOI:10.3748/wjg.v28. i30.4053.
Search in Google Scholar Back to article
Kim J, Lee HK. Potential role of the gut microbiome in colorectal cancer progression. Front Immunol. 2022;12:807648; DOI:10.3389/fimmu.2021.807648.
Search in Google Scholar Back to article
Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010;90(3):859-904; DOI:10.1152/physrev.00045.2009.
Search in Google Scholar Back to article
Quigley EM. Gut bacteria in health and disease. Gastroenterol Hepatol (NY). 2013;9(9):560-569.
Search in Google Scholar Back to article
Roy Sarkar S, Banerjee S. Gut microbiota in neurodegenerative disorders. J Neuroimmunol. 2019;328:98-104; DOI:10.1016/j. jneuroim.2019.01.004.
Search in Google Scholar Back to article
Rebersek M. Gut microbiome and its role in colorectal cancer. BMC Cancer. 2021;21(1):1325; DOI:10.1186/s12885-021-09054-2.
Search in Google Scholar Back to article
Wong SH, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol. 2019;16(11):690-704; DOI:10.1038/s41575-019-0209-8.
Search in Google Scholar Back to article
DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis. 2016;22(5):1137-1150; DOI:10.1097/MIB.0000000000000750.
Search in Google Scholar Back to article
Grenham S, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbe communication in health and disease. Front Physiol. 2011;2:94; DOI:10.3389/fphys.2011.00094.
Search in Google Scholar Back to article
Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nat Med. 2019;25(3):377-388; DOI:10.1038/s41591-019-0377-7.
Search in Google Scholar Back to article
Hakansson A, Molin G. Gut microbiota and inflammation. Nutrients. 2011;3(6):637-682. DOI: 10.3390/nu3060637.
Search in Google Scholar Back to article
Al Bander Z, Nitert MD, Mousa A, Naderpoor N. The Gut microbiota and inflammation: an overview. Int J Environ Res Public Health. 2020;17(20):7618; DOI:10.3390/ijerph17207618.
Search in Google Scholar Back to article
Gomaa EZ. Human gut microbiota/microbiome in health and diseases: a review. Antonie Van Leeuwenhoek. 2020;113(12):2019-2040; DOI:10.1007/s10482-020-01474-7.
Search in Google Scholar Back to article
Lakatos PL, Lakatos L. Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J Gastroenterol. 2008;14(25):3937-3947; DOI:10.3748/wjg.14.3937.
Search in Google Scholar Back to article
Freeman HJ. Colorectal cancer risk in Crohn’s disease. World J Gastroenterol. 2008;14(12):1810-1811; DOI:10.3748/wjg.14.1810.
Search in Google Scholar Back to article
Song M, Chan AT, Sun J. Influence of the gut microbiome, diet, and environment on risk of colorectal cancer. Gastroenterology. 2020;158(2):322-340; DOI:10.1053/j.gastro.2019.06.048.
Search in Google Scholar Back to article
Coker OO, Nakatsu G, Dai RZ, Wu WKK, Wong SH, Ng SC, Chan FKL, Sung JJY, Yu J. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer. Gut. 2019;68(4):654-662; DOI:10.1136/gutjnl-2018-317178.
Search in Google Scholar Back to article
Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One. 2012;7(6):e39743; DOI:10.1371/journal.pone.0039743.
Search in Google Scholar Back to article
Gupta A, Madani R, Mukhtar H. Streptococcus bovis endocarditis, a silent sign for colonic tumour. Colorectal Dis. 2010;12(3):164-171; DOI:10.1111/j.1463-1318.2009.01814.x.
Search in Google Scholar Back to article
Boleij A, van Gelder MM, Swinkels DW, Tjalsma H. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis. 2011;53(9):870-878; DOI:10.1093/cid/cir609.
Search in Google Scholar Back to article
Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22(2):299-306; DOI:10.1101/gr.126516.111.
Search in Google Scholar Back to article
Ye X, Wang R, Bhattacharya R, Boulbes DR, Fan F, Xia L, Adoni H, Ajami NJ, Wong MC, Smith DP, Petrosino JF, Venable S, Qiao W, Baladandayuthapani V, Maru D, Ellis LM. Fusobacterium nucleatum subspecies Animalis influences proinflammatory cytokine expression and monocyte activation in human colorectal tumors. Cancer Prev Res (Phila). 2017;10(7):398-409; DOI:10.1158/1940-6207.CAPR-16-0178.
Search in Google Scholar Back to article
Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Jia W, Cai S, Zhao L. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012;6(2):320-329; DOI:10.1038/ismej.2011.109.
Search in Google Scholar Back to article
Toprak NU, Yagci A, Gulluoglu BM, Akin ML, Demirkalem P, Celenk T, Soyletir G. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect. 2006;12(8):782-786; DOI:10.1111/j.1469-0691.2006.01494.x.
Search in Google Scholar Back to article
Dai Z, Zhang J, Wu Q, Chen J, Liu J, Wang L, Chen C, Xu J, Zhang H, Shi C, Li Z, Fang H, Lin C, Tang D, Wang D. The role of microbiota in the development of colorectal cancer. Int J Cancer. 2019;145(8):2032-2041; DOI:10.1002/ijc.32017.
Search in Google Scholar Back to article
Tsoi H, Chu ESH, Zhang X, Sheng J, Nakatsu G, Ng SC, Chan AWH, Chan FKL, Sung JJY, Yu J. Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice. Gastroenterology. 2017;152(6):1419-1433.e5; DOI:10.1053/j.gastro.2017.01.009.
Search in Google Scholar Back to article
Gao Z, Guo B, Gao R, Zhu Q, Qin H. Microbiota disbiosis is associated with colorectal cancer. Front Microbiol. 2015;6:20; DOI:10.3389/fmicb.2015.00020.
Search in Google Scholar Back to article
He Z, Gharaibeh RZ, Newsome RC, Pope JL, Dougherty MW, Tomkovich S, Pons B, Mirey G, Vignard J, Hendrixson DR, Jobin C. Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin. Gut. 2019;68(2):289-300; DOI:10.1136/gutjnl-2018-317200.
Search in Google Scholar Back to article
Figliuolo VR, Dos Santos LM, Abalo A, Nanini H, Santos A, Brittes NM, Bernardazzi C, de Souza HSP, Vieira LQ, Coutinho-Silva R, Coutinho CMLM. Sulfate-reducing bacteria stimulate gut immune responses and contribute to inflammation in experimental colitis. Life Sci. 2017;189:29-38; DOI:10.1016/j.lfs.2017.09.014.
Search in Google Scholar Back to article
Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661-672; DOI:10.1038/nrmicro3344.
Search in Google Scholar Back to article
Barzak B., Hankus K., Parmar S., Wozniak S. The effect of physical activity on gut microbiota. A review. Med J Cell Biol. 2022;10(4):138-143; DOI:10.2478/ACB-2022-0021.
Search in Google Scholar Back to article
Wozniak S, Nowinska K, Chabowski M, Dziegiel P. Significance of Irisin (FNDC5) expression in colorectal cancer. in vivo. 2022;36(1):180-188; DOI:10.21873/invivo.12689.
Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.2478/acb-2023-0004 | Journal eISSN: 2544-3577

Journal RSS Feed

Language: English

Page range: 28 - 32

Submitted on: Feb 10, 2023

Accepted on: Mar 2, 2023

Published on: Aug 31, 2023

Published by: Foundation for Cell Biology and Molecular Biology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

gut microbiota,

inflammation-dysplasia-cancer sequence,

colon cancer,

colorectal cancer,

dysbiosis,

colon cancer risk factors

Related subjects:

Life sciences,

Molecular biology,

Biochemistry

© 2023 Ivanna Lazarchuk, Shivika Parmar, Slawomir Wozniak, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 11 (2023): Issue 1 (July 2023)